Featured Content

Embracing Digital Platforms for Combination Products

Although still in the early stages of their development, digital healthcare platforms have the potential to improve patient outcomes, reduce healthcare costs, and allow communication and collaboration between doctors on a global scale. Pharma IQ spoke exclusively with Helene Gustafsson, Head of Regulatory & Clinical Compliance, LEO Pharma to discuss the utilisation of digital platforms alongside drug-device combination products.

The Drug-Device Combination Products Market Report

The global drug device combination product market is expected to reach USD 177.7 billion by 2024. With input from Medical Device Manufacturers, Pharmaceuticals, Consultants and Solution Providers, this report will explore the key drivers and challenges faced in the drug-device combination products market. 

5 Key Considerations For Combination Product Regulations

The market for combination products is rapidly expanding, these products are advancing medical care and will likely have a significant impact on the industry in the coming years. Pharma IQ sat down with Audrey Clarembeaux, Head of Medical Device Development QA at UCB to discuss the key considerations that need to be made when ensuring regulatory compliance in combination products.

Optimising Combination Product Development Using the E-Health Wave

Steve Dew, Associate Director Medical Devices and Combination Products, Biogen offered his insights into Optimising Combination Product Development Using the E-Health Wave, providing delegates with some thoughts about how digital health will transform the way we view combination products in patient care.